The parallel importation of pharmaceuticals in Kenya—legally enabled under Section 58(2) of the Industrial Property Act (2001) and regulated by the Pharmacy and Poisons (Parallel Imported Medicinal Substances) Rules (2019)—offers a bold opportunity to bring genuine, patented drugs from lower-price markets without needing the rights holder’s consent. This initiative, designed to enhance affordability and access …
Continue reading “Impact of Parallel Drug Imports on Kenyan Healthcare.”
Fun and Health. 